Helptext

Movies



Company Information

Company NameEurocine Vaccines AB
Company Idea

Eurocine Vaccines is a publicly listed, clinical-stage company developing nasal vaccines that meet important medical needs. The vaccines are developed up to proof of concept (clinical phase I/II) and licensed to partners for further development and commercialization. The company's proprietary vaccine adjuvant technologies, which are a key element of the nasal vaccines, are also offered to license partners for development in various indications.

Present focus is on partnering the nasal influenza vaccine program, Immunose™ FLU, which has shown proof of concept in a clinical study, and on preclinical development of a nasal vaccine against bacterial pneumonia.

Phone070-634 0171CEOHans Arwidsson
E-mailinfo(snabel-a)eurocine-vaccines(punkt)comChairm. of the BoardMichael Wolff Jensen
Homepagehttp://www.eurocine-vaccines.com 

Instrument Information

Full NameEurocine VaccinesShort NameEUCI
No of shares53,458,721Par Value0.11 SEK
TypeShareISIN codeSE0001839069

Price Information

+/-0.03
%0.78
Latest3.89
High3.95
Low3.85
Volume36,546
Turnover (SEK)142,577
Market Cap (MSEK)208

Orders

VolumeBidAskVolume

Deals

TimeBuyerSellerPriceVolume
5:29 PMAVAAVA3.89200
5:20 PMAVANRD3.90100
4:44 PMSWBAVA3.91486
4:44 PMSWBAVA3.91532
4:44 PMSWBSWB3.912,482
4:29 PMNONSWB3.91250
4:25 PMNONSWB3.91268
4:25 PMNONAVA3.91532
4:23 PMNONAVA3.911,028
4:23 PMNONAVA3.91472

Scheduled Reports

DateReport
2017-08-23Bokslutskommuniké för 2016/2017




  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se